Neural damage in the lenticular nucleus linked with tardive dyskinesia in schizophrenia: A preliminary study using proton magnetic resonance spectroscopy

Schizophrenia Research

Volumn 57, Issue 2-3, 2002, Pages 273-279

  Ando, Katsuhisa ^a   Takei, Nori ^a,b   Matsumoto, Hideo ^a   Iyo, Masaomi ^c   Isoda, Haruo ^a   Mori, Norio ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c CHIBA UNIVERSITY   (Japan)

Author keywords

Basal ganglia system; Choline; Magnetic resonance spectroscopy; Schizophrenia; Tardive dyskinesia

Indexed keywords

CHOLINE; CREATINE; HALOPERIDOL; N ACETYLASPARTIC ACID; NEUROLEPTIC AGENT;

ADULT; ARTICLE; BASAL GANGLION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MALE; NERVE INJURY; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; RANK SUM TEST; SCHIZOPHRENIA; STATISTICAL SIGNIFICANCE; TARDIVE DYSKINESIA;

ADULT; ANTIPSYCHOTIC AGENTS; ASPARTIC ACID; CASE-CONTROL STUDIES; CHOLINE; CORPUS STRIATUM; CREATINE; DYSKINESIA, DRUG-INDUCED; FEMALE; HUMANS; LINEAR MODELS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; SCHIZOPHRENIA; STATISTICS, NONPARAMETRIC;

EID: 0036773663     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0920-9964(01)00290-0     Document Type: Article

References (38)

1. Bartels M., Themelis J. Computerized tomography in tardive dyskinesia: evidence of structural abnormalities in the basal ganglia system. Arch. Psychiatr. Nervenkrankh. 233:1983;371-379.
2. Benes F.M., Paskevich P.A., Davidson J., Domesick V.B. The effects of haloperidol on synaptic patterns in the rat striatum. Brain Res. 329:1985;265-273.
3. Bertolino A., Nawroz S., Mattay V.S., Barnett A.S., Duyn J.H., Moonen C.T., Frank J.A., Tedeschi G., Weinberger D.R. Regionally specific pattern of neurochemical pathology in schizophrenia as assessed by multislice proton magnetic resonance spectroscopic imaging. Am. J. Psychiatry. 153:1996;1554-1563.
4. 1H-magnetic resonance spectroscopy of the left temporal and frontal lobes in schizophrenia: clinical, neurodevelopmental, and cognitive correlates. Biol. Psychiatry. 36:1994;792-800.
5. Chatterjee A., Chakos M., Koreen A., Geisler S., Sheitman B., Woerner M., Kane J.M., Alvir J., Lieberman J.A. Prevalence and clinical correlates of extrapyramidal signs and spontaneous dyskinesia in never-medicated schizophrenic patients. Am. J. Psychiatry. 152:1995;1724-1729.
6. 1H magnetic resonance spectroscopy characterization of neuronal dysfunction in drug-naive, chronic schizophrenia. Acad. Radiol. 1:1994;211-216.
7. Chong W.K., Sweeney B., Wilkinson I.D., Paley M., Hall-Craggs M.A., Kendall B.E., Shepard J.K., Beecham M., Miller R.F., Weller I.V. Proton spectroscopy of the brain in HIV infection: correlation with clinical, immunologic, and MR imaging findings. Radiology. 188:1993;119-124.
8. Dalgalarrondo P., Gattaz W.F. Basal ganglia abnormalities in tardive dyskinesia: possible relationship with duration of neuroleptic treatment. Eur. Arch. Psychiatry Clin. Neurosci. 244:1994;272-277.
9. Davidson J.R., Krishnan K.R., Charles H.C., Boyko O., Potts N.L., Ford S.M., Patterson L. Magnetic resonance spectroscopy in social phobia: preliminary findings. J. Clin. Psychiatry. 54:1993;19-25. Suppl.
10. Dawson R.M.C. Enzymatic pathways of phospholipid metabolism in the nervous system. Eichberg J. Phospholipids in Nervous Tissues. 1985;45-78 Wiley, New York.
11. Deicken R.F., Zhou L., Schuff N., Weiner M.W. Proton magnetic resonance spectroscopy of the anterior cingulate region in schizophrenia. Schizophr. Res. 27:1997;65-71.
12. Frahm J., Bruhn H., Gyngell M.L., Merboldt K.D., Hanicke W., Sauter R. Localized proton NMR spectroscopy in different regions of the human brain in vivo, relaxation times and concentrations of cerebral metabolites. Magn. Reson. Med. 11:1989;47-63.
13. Fujimoto T., Nakano T., Takano T., Takeuchi K., Yamada K., Fukuzako T., Akimoto H. Proton magnetic resonance spectroscopy of basal ganglia in chronic schizophrenia. Biol. Psychiatry. 40:1996;14-18.
14. Fukuzako H., Takeuchi K., Hokazono Y., Fukuzako T., Yamada K., Hashiguchi T., Obo Y., Ueyama K., Takigawa M., Fujimoto T. Proton magnetic resonance spectroscopy of the left medial temporal and frontal lobes in chronic schizophrenia: preliminary report. Psychiatry Res. 61:1995;193-200.
15. Gardos G., Cole J.O., Haskell D., Marby D., Paine S.S., Moore P. The natural history of tardive dyskinesia. J. Clin. Psychopharmacol. 8(4 Suppl.):1988;31S-37S.
16. Gervin M., Browne S., Lane A., Clarke M., Waddington J.L., Larkin C., O'Callaghan E. Spontaneous abnormal involuntary movements in first-episode schizophrenia and schizophreniform disorder: baseline rate in a group of patients from an Irish catchment area. Am. J. Psychiatry. 155:1998;202-206.
17. Heimberg C., Komoroski R.A., Lawson W.B., Cardwell D., Karson C.N. Regional proton magnetic resonance spectroscopy in schizophrenia and exploration of drug effect. Psychiatry Res. 83:1998;105-115.
18. Jarvik J.G., Lenkinski R.E., Grossman R.I., Gomori J.M., Schnall M.D., Frank I. Proton MR spectroscopy of HIV-infected patients: characterization of abnormalities with imaging and clinical correlation. Radiology. 186:1993;739-744.
19. Jeste D.V., Lohr J.B., Manley M. Study of neuropathologic changes in the striatum following 4, 8 and 12 months of treatment with fluphenazine in rats. Psychopharmacology (Berlin). 106:1992;154-160.
20. Kane J.M., Woerner M., Lieberman J. Tardive dyskinesia: prevalence, incidence, and risk factors. J. Clin. Psychopharmacol. 8(4 Suppl.):1988;52S-56S.
21. Kay S.R., Fiszbein A., Opler L.A. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr. Bull. 13:1987;261-276.
22. Lewis L.D., Ljunggren B., Ratcheson R.A., Siesjo B.K. Cerebral energy state in insulin-induced hypoglycemia, related to blood glucose and to EEG. J. Neurochem. 23:1974;673-679.
23. Lindquist D.M., Hawk R.M., Karson C.N., Komoroski R.A. Effects of antipsychotic drugs on metabolite ratios in rat brain in vivo. Magn. Reson. Med. 43:2000;355-358.
24. Maier M., Ron M.A., Barker G.J., Tofts P.S. Proton magnetic resonance spectroscopy: an in vivo method of estimating hippocampal neuronal depletion in schizophrenia. Psychol. Med. 25:1995;1201-1209.
25. Menon D.K., Baudouin C.J., Tomlinson D., Hoyle C. Proton MR spectroscopy and imaging of the brain in AIDS: evidence of neuronal loss in regions that appear normal with imaging. J. Comput. Assist. Tomogr. 14:1990;882-885.
26. Meshul C.K., Janowsky A., Casey D.E., Stallbaumer R.K., Taylor B. Effect of haloperidol and clozapine on the density of "perforated" synapses in caudate, nucleus accumbens, and medial prefrontal cortex. Psychopharmacology (Berlin). 106:1992;45-52.
27. Miller B.L., Moats R.A., Shonk T., Ernst T., Woolley S., Ross B.D. Alzheimer's disease: depiction of increased cerebral myo-inositol with proton MR spectroscopy. Radiology. 187:1993;433-437.
28. Mion C.C., Andreasen N.C., Arndt S., Swayze V.W. II, Cohen G.A. MRI abnormalities in tardive dyskinesia. Psychiatry Res. 40:1991;157-166.
29. Morgenstern H., Glazer W.M. Identifying risk factors for tardive dyskinesia among long-term outpatients maintained with neuroleptic medications: results of the Yale tardive dyskinesia study. Arch. Gen. Psychiatry. 50:1993;723-733.
30. Overall J.E., Gorham D.R. Brief psychiatric rating scale. Psychol. Rep. 10:1962;799-812.
31. Porcellati G., Arienti G. Metabolism of phosphoglycerides. Lajtha A. Handbook of Neurochemistry, Metabolism in the Nervous System. 1983;133-161 Plenum, New York.
32. Psychopharmachological Research Branch, NIMH, 1975. Development of a dyskinesic movement scale. ECDEU Intercom 4: 1, 3.
33. Schooler N.R., Kane J.M. Research diagnoses for tardive dyskinesia. Arch. Gen. Psychiatry. 39:1982;486-487.
34. Sharma R., Venkatasubramanian P.N., Barany M., Davis J.M. Proton magnetic resonance spectroscopy of the brain in schizophrenic and affective patients. Schizophr. Res. 8:1992;43-49.
35. Shioiri T., Hamakawa H., Kato T., Murashita J., Fujii K., Inubushi T., Takahashi S. Proton magnetic resonance spectroscopy of the basal ganglia in patients with schizophrenia: a preliminary report. Schizophr. Res. 22:1996;19-26.
36. Shonk T.K., Moats R.A., Gifford P., Michaelis T., Mandigo J.C., Izumi J., Ross B.D. Probable Alzheimer's disease: diagnosis with proton MR spectroscopy. Radiology. 195:1995;65-72.
37. SPSS 7.5. SPSS, Chicago, IL
38. Yurgelun-Todd D.A., Renshaw P.F., Gruber S.A., Ed M., Waternaux C., Cohen B.M. Proton magnetic resonance spectroscopy of the temporal lobes in schizophrenics and normal controls. Schizophr. Res. 19:1996;55-59.